Operating Lease, Right-of-Use Asset of Q32 Bio Inc. from 01 Jan 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Q32 Bio Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2020 to 30 Sep 2025.
  • Q32 Bio Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $5,258,000, a 10% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Q32 Bio Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,258,000 -$611,000 -10% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $5,416,000 -$600,000 -10% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $5,571,000 -$589,000 -9.6% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $5,722,000 -$579,000 -9.2% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $5,869,000 -$13,602,000 -70% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $6,016,000 -$13,821,000 -70% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $6,160,000 -$14,040,000 -70% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $6,301,000 -$14,262,000 -69% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $19,471,000 -$1,429,000 -6.8% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $19,837,000 +$4,686,000 +31% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $20,200,000 +$4,591,000 +29% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $20,563,000 +$4,956,000 +32% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $20,900,000 +$15,872,000 +316% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $15,151,000 +$9,823,000 +184% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $15,609,000 +$9,991,000 +178% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $15,607,000 +$9,710,000 +165% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $5,028,000 -$1,121,000 -18% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $5,328,000 -$1,058,000 -17% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $5,618,000 -$997,000 -15% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $5,897,000 -$938,000 -14% 31 Dec 2020 10-K 23 Mar 2022 2021 FY
Q3 2020 $6,149,000 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $6,386,000 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $6,615,000 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $6,835,000 01 Jan 2020 10-K 23 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.